Identifying Targets to Prevent Aminoglycoside Ototoxicity
Overview
Molecular Biology
Neurology
Affiliations
Aminoglycosides are potent antibiotics that are commonly prescribed worldwide. Their use carries significant risks of ototoxicity by directly causing inner ear hair cell degeneration. Despite their ototoxic side effects, there are currently no approved antidotes. Here we review recent advances in our understanding of aminoglycoside ototoxicity, mechanisms of drug transport, and promising sites for intervention to prevent ototoxicity.
Inhibition of GABARAP or GABARAPL1 prevents aminoglycoside- induced hearing loss.
Li J, Oh S, Liu C, Zhao B Proc Natl Acad Sci U S A. 2025; 122(7):e2416453122.
PMID: 39928869 PMC: 11848329. DOI: 10.1073/pnas.2416453122.
Wu P, Barros-Becker F, Ogelman R, Camci E, Linbo T, Simon J Front Neurol. 2024; 15:1480435.
PMID: 39610699 PMC: 11602426. DOI: 10.3389/fneur.2024.1480435.
Jeong M, Kurihara S, Stankovic K Antioxidants (Basel). 2024; 13(11).
PMID: 39594548 PMC: 11591063. DOI: 10.3390/antiox13111407.
Fong M, Paik C, Quinones P, Walker C, Serafino M, Pan D Sci Rep. 2024; 14(1):25660.
PMID: 39465341 PMC: 11514180. DOI: 10.1038/s41598-024-77154-7.
Crosslinked-hybrid nanoparticle embedded in thermogel for sustained co-delivery to inner ear.
Thakur N, Rus I, Herbert A, Zallocchi M, Chakrabarty B, Joshi A J Nanobiotechnology. 2024; 22(1):482.
PMID: 39135039 PMC: 11321169. DOI: 10.1186/s12951-024-02686-z.